Deng Lin, Wu Bei, Lou Jianlin, Zhang Chen, Huang An, Gu An, Chen Haiqin, Wang Lina
School of Medicine, Huzhou University, Huzhou, Zhejiang, China.
Rory Meyers College of Nursing, New York University, New York, NY, United States.
Front Psychiatry. 2025 May 27;16:1551160. doi: 10.3389/fpsyt.2025.1551160. eCollection 2025.
Patients with mental disorders often exhibit unique challenges in medication adherence, comprehension of drug information, and self-management abilities, underscoring the need for a specialized assessment tool to accurately reflect their medication literacy levels and support targeted clinical interventions.
A stepwise, mixed-methods design was adopted to develop the Medication Literacy Assessment Scale. Preliminary items were generated through a comprehensive literature review and semi-structured interviews with 20 patients and 6 psychiatric professionals. Then, a two-round Delphi study was conducted to refine the scale based on expert consensus. Quantitative analysis of expert feedback guided the scale's refinement, ensuring it effectively captures the unique aspects of medication literacy for patients with mental disorders in recovery.
The finalized Medication Literacy Assessment Scale for patients with mental disorders in recovery was developed, yielding 35 items across four dimensions: functional literacy (10 items), communicative literacy (6 items), critical literacy (11 items), and numeracy (8 items). Each dimension reflects essential aspects of medication literacy specific to this population, as identified through expert consensus.
This study developed a preliminary, standardized tool for assessing medication literacy in patients with mental disorders during recovery, with the potential to identify individuals at risk of medication mismanagement and to enable targeted interventions and improved outcomes in China's healthcare system. Although its psychometric properties have not yet been evaluated in this stage, future research will conduct empirical validation to establish its measurement reliability and validity.
精神障碍患者在药物依从性、药物信息理解和自我管理能力方面常常面临独特挑战，这凸显了需要一种专门的评估工具来准确反映他们的用药知识水平，并支持有针对性的临床干预。
采用逐步混合方法设计来开发用药知识评估量表。通过全面的文献综述以及对20名患者和6名精神科专业人员进行半结构化访谈生成初步条目。然后，进行两轮德尔菲研究，根据专家共识完善该量表。对专家反馈进行定量分析以指导量表的完善，确保其有效捕捉康复期精神障碍患者用药知识的独特方面。
最终开发出了针对康复期精神障碍患者的用药知识评估量表，该量表在四个维度上有35个条目：功能知识（10个条目）、沟通知识（6个条目）、批判性知识（11个条目）和算术能力（8个条目）。每个维度都反映了通过专家共识确定的该人群用药知识的重要方面。
本研究开发了一种初步的标准化工具，用于评估康复期精神障碍患者的用药知识，有可能识别出药物管理不当风险的个体，并在中国医疗体系中实现有针对性的干预并改善治疗效果。尽管在此阶段其心理测量特性尚未评估，但未来研究将进行实证验证以确定其测量的可靠性和有效性。
